ZA200710798B - Pyrazolo [3, 4-D] azepine derivatives as histamine H3 antagonists - Google Patents
Pyrazolo [3, 4-D] azepine derivatives as histamine H3 antagonistsInfo
- Publication number
- ZA200710798B ZA200710798B ZA200710798A ZA200710798A ZA200710798B ZA 200710798 B ZA200710798 B ZA 200710798B ZA 200710798 A ZA200710798 A ZA 200710798A ZA 200710798 A ZA200710798 A ZA 200710798A ZA 200710798 B ZA200710798 B ZA 200710798B
- Authority
- ZA
- South Africa
- Prior art keywords
- antagonists
- pyrazolo
- histamine
- azepine derivatives
- derivatives
- Prior art date
Links
- 239000003395 histamine H3 receptor antagonist Substances 0.000 title 1
- RMUDBHOUKWNOLH-UHFFFAOYSA-N pyrazolo[3,4-d]azepine Chemical class C1=CN=CC=C2C=NN=C21 RMUDBHOUKWNOLH-UHFFFAOYSA-N 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003217 pyrazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0513886.2A GB0513886D0 (en) | 2005-07-06 | 2005-07-06 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710798B true ZA200710798B (en) | 2008-11-26 |
Family
ID=34856781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710798A ZA200710798B (en) | 2005-07-06 | 2007-12-12 | Pyrazolo [3, 4-D] azepine derivatives as histamine H3 antagonists |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7888347B2 (enExample) |
| EP (1) | EP1899350B1 (enExample) |
| JP (1) | JP5145218B2 (enExample) |
| KR (1) | KR20080037651A (enExample) |
| CN (1) | CN101258154B (enExample) |
| AT (1) | ATE467636T1 (enExample) |
| AU (1) | AU2006286897A1 (enExample) |
| BR (1) | BRPI0612719A2 (enExample) |
| CA (1) | CA2614232A1 (enExample) |
| CR (1) | CR9622A (enExample) |
| CY (1) | CY1110711T1 (enExample) |
| DE (1) | DE602006014273D1 (enExample) |
| DK (1) | DK1899350T3 (enExample) |
| EA (1) | EA013600B1 (enExample) |
| ES (1) | ES2345841T3 (enExample) |
| GB (1) | GB0513886D0 (enExample) |
| HR (1) | HRP20100401T1 (enExample) |
| IL (1) | IL188184A0 (enExample) |
| MA (1) | MA29623B1 (enExample) |
| MX (1) | MX2008000383A (enExample) |
| NO (1) | NO20080563L (enExample) |
| PL (1) | PL1899350T3 (enExample) |
| PT (1) | PT1899350E (enExample) |
| SI (1) | SI1899350T1 (enExample) |
| UA (1) | UA93047C2 (enExample) |
| WO (1) | WO2007025596A1 (enExample) |
| ZA (1) | ZA200710798B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2655604C (en) | 2006-06-23 | 2016-08-09 | Abbott Laboratories | Cyclopropyl amine derivatives |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| CN101868457B (zh) | 2007-09-24 | 2013-02-13 | 科门蒂斯公司 | 作为β-分泌酶抑制剂用于治疗的(3-羟基-4-氨基-丁-2-基)-3-(2-噻唑-2-基-吡咯烷-1-羰基)苯甲酰胺衍生物和相关化合物 |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| US8853390B2 (en) | 2010-09-16 | 2014-10-07 | Abbvie Inc. | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| CN102952139B (zh) * | 2011-08-30 | 2016-08-10 | 上海药明康德新药开发有限公司 | 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法 |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| EP2647377A1 (en) | 2012-04-06 | 2013-10-09 | Sanofi | Use of an h3 receptor antagonist for the treatment of alzheimer's disease |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| US9910887B2 (en) * | 2013-04-25 | 2018-03-06 | Facebook, Inc. | Variable search query vertical access |
| JP2019520335A (ja) * | 2016-05-25 | 2019-07-18 | アカーナ・セラピューティクス・リミテッドＡｋａｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｔｄ． | 疾患治療用の縮合二環式化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9913503A (pt) * | 1998-09-09 | 2002-01-29 | Ishihara Sangyo Kaisha | Derivados de benzeno-fundidos úteis como herbicidas |
| EP1173438A1 (en) * | 1999-04-16 | 2002-01-23 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
| JP2001220390A (ja) | 2000-02-09 | 2001-08-14 | Yamanouchi Pharmaceut Co Ltd | 縮合ピラゾール誘導体 |
| AU2003229535A1 (en) * | 2002-06-06 | 2003-12-22 | Novo Nordisk A/S | Substituted hexahydropyrrolo(1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| US6770597B2 (en) | 2002-07-17 | 2004-08-03 | Ishihara Sangyo Kaisha, Ltd. | Benzohydrazide derivatives as herbicides and desiccant compositions containing them |
| MXPA05000945A (es) | 2002-07-25 | 2005-05-16 | Pharmacia Italia Spa | Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. |
| AU2003256793A1 (en) * | 2002-08-20 | 2004-03-11 | Eli Lilly And Company | Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| GB0224083D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| PT1572215E (pt) | 2002-12-20 | 2009-12-09 | Glaxo Group Ltd | Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas |
| SG146683A1 (en) * | 2003-09-17 | 2008-10-30 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as serotonin receptor modulators |
| GB0329214D0 (en) | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Novel compounds |
| GB0405628D0 (en) | 2004-03-12 | 2004-04-21 | Glaxo Group Ltd | Novel compounds |
| GB0408083D0 (en) | 2004-04-08 | 2004-05-12 | Glaxo Group Ltd | Novel compounds |
| TW200611701A (en) | 2004-06-18 | 2006-04-16 | Glaxo Group Ltd | Novel compounds |
| GB0418267D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Novel compounds |
| BRPI0518841A2 (pt) | 2004-12-07 | 2008-12-09 | Glaxo Group Ltd | derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos |
| KR20070113225A (ko) | 2005-03-14 | 2007-11-28 | 글락소 그룹 리미티드 | 히스타민 ｈ３ 수용체에 대해 친화성을 갖는 융합된 티아졸유도체 |
-
2005
- 2005-07-06 GB GBGB0513886.2A patent/GB0513886D0/en not_active Ceased
-
2006
- 2006-07-04 SI SI200630733T patent/SI1899350T1/sl unknown
- 2006-07-04 DK DK06818218.7T patent/DK1899350T3/da active
- 2006-07-04 MX MX2008000383A patent/MX2008000383A/es active IP Right Grant
- 2006-07-04 UA UAA200800190A patent/UA93047C2/ru unknown
- 2006-07-04 AU AU2006286897A patent/AU2006286897A1/en not_active Abandoned
- 2006-07-04 AT AT06818218T patent/ATE467636T1/de active
- 2006-07-04 JP JP2008519862A patent/JP5145218B2/ja not_active Expired - Fee Related
- 2006-07-04 ES ES06818218T patent/ES2345841T3/es not_active Expired - Lifetime
- 2006-07-04 PT PT06818218T patent/PT1899350E/pt unknown
- 2006-07-04 CA CA002614232A patent/CA2614232A1/en not_active Abandoned
- 2006-07-04 US US11/994,689 patent/US7888347B2/en not_active Expired - Fee Related
- 2006-07-04 HR HR20100401T patent/HRP20100401T1/hr unknown
- 2006-07-04 KR KR1020087000265A patent/KR20080037651A/ko not_active Ceased
- 2006-07-04 EP EP06818218A patent/EP1899350B1/en not_active Expired - Lifetime
- 2006-07-04 EA EA200800264A patent/EA013600B1/ru not_active IP Right Cessation
- 2006-07-04 PL PL06818218T patent/PL1899350T3/pl unknown
- 2006-07-04 BR BRPI0612719-3A patent/BRPI0612719A2/pt not_active IP Right Cessation
- 2006-07-04 DE DE602006014273T patent/DE602006014273D1/de not_active Expired - Lifetime
- 2006-07-04 CN CN2006800322776A patent/CN101258154B/zh not_active Expired - Fee Related
- 2006-07-04 WO PCT/EP2006/006613 patent/WO2007025596A1/en not_active Ceased
-
2007
- 2007-12-12 ZA ZA200710798A patent/ZA200710798B/xx unknown
- 2007-12-17 IL IL188184A patent/IL188184A0/en unknown
- 2007-12-20 CR CR9622A patent/CR9622A/es not_active Application Discontinuation
-
2008
- 2008-01-09 MA MA30562A patent/MA29623B1/fr unknown
- 2008-01-30 NO NO20080563A patent/NO20080563L/no not_active Application Discontinuation
-
2010
- 2010-07-29 CY CY20101100713T patent/CY1110711T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101258154A (zh) | 2008-09-03 |
| HRP20100401T1 (hr) | 2010-09-30 |
| EP1899350B1 (en) | 2010-05-12 |
| WO2007025596A1 (en) | 2007-03-08 |
| CR9622A (es) | 2008-04-10 |
| BRPI0612719A2 (pt) | 2010-11-30 |
| EA200800264A1 (ru) | 2008-06-30 |
| UA93047C2 (ru) | 2011-01-10 |
| JP2009500366A (ja) | 2009-01-08 |
| MX2008000383A (es) | 2008-03-07 |
| AU2006286897A1 (en) | 2007-03-08 |
| PT1899350E (pt) | 2010-07-21 |
| NO20080563L (no) | 2008-02-01 |
| MA29623B1 (fr) | 2008-07-01 |
| CN101258154B (zh) | 2011-01-19 |
| ATE467636T1 (de) | 2010-05-15 |
| SI1899350T1 (sl) | 2010-09-30 |
| PL1899350T3 (pl) | 2010-10-29 |
| KR20080037651A (ko) | 2008-04-30 |
| EA013600B1 (ru) | 2010-06-30 |
| ES2345841T3 (es) | 2010-10-04 |
| EP1899350A1 (en) | 2008-03-19 |
| DE602006014273D1 (de) | 2010-06-24 |
| DK1899350T3 (da) | 2010-09-06 |
| IL188184A0 (en) | 2008-03-20 |
| GB0513886D0 (en) | 2005-08-10 |
| JP5145218B2 (ja) | 2013-02-13 |
| US20080176832A1 (en) | 2008-07-24 |
| US7888347B2 (en) | 2011-02-15 |
| CA2614232A1 (en) | 2007-03-08 |
| CY1110711T1 (el) | 2015-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0329214D0 (en) | Novel compounds | |
| IL188184A0 (en) | Pyrazolo [3,4-d] azepine derivatives as histamine h3 antagonists | |
| TW200500344A (en) | Novel compounds | |
| DE602006005477D1 (en) | Imidazopyridinverbindungen | |
| TW200503713A (en) | Novel compounds | |
| TW200621716A (en) | Novel compounds | |
| TW200503710A (en) | Novel compounds | |
| MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
| GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
| TW200730525A (en) | Therapeutic agents | |
| TW200514781A (en) | Novel compounds | |
| IL185869A0 (en) | Fused thiazole derivatives having affinity for the histamine h3 receptor | |
| TW200611701A (en) | Novel compounds | |
| MY133479A (en) | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | |
| GB0420831D0 (en) | Novel compounds | |
| MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
| MXPA05011163A (es) | Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides. | |
| WO2005097778A8 (en) | Tetrahydrobenzazepines as histamine h3 receptor ligands | |
| TW200621255A (en) | Novel compounds | |
| WO2004056821A3 (en) | Quinolizidine derivatives |